Sabra Health Care REIT Sees FY24 Normalized AFFO $1.39-$1.43
Portfolio Pulse from Benzinga Newsdesk
Sabra Health Care REIT (SBRA) has reiterated its FY24 earnings guidance, with a focus on strong portfolio growth and a healthy balance sheet. The guidance includes Net Income of $0.53-$0.57, FFO of $1.33-$1.37, Normalized FFO of $1.34-$1.38, AFFO of $1.38-$1.42, and Normalized AFFO of $1.39-$1.43 per diluted common share. CEO Rick Matros highlighted the company's portfolio strength, including improvements in SNF coverage and the SHOP portfolio, and teased potential new investments in the next quarter.
May 08, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sabra Health Care REIT maintains its FY24 earnings guidance, indicating strong portfolio performance and potential for future growth.
The reiteration of earnings guidance by Sabra Health Care REIT, coupled with the CEO's positive remarks on the portfolio's performance and the hint at future investments, suggests a strong outlook for the company. This positive guidance and strategic optimism are likely to instill confidence in investors, potentially leading to a positive short-term impact on SBRA's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100